SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

One bad Apple: Apple settles lawsuit over alleged discrimination against Jewish employee

Azrieli expands London data center in eight-year, $34M-per-year deal

Full list of Israeli high-tech funding rounds in 2026

Remepy raises $36 million Series A as it prepares AI-driven Parkinson’s treatment for Phase III

Buzz

Most popular

Daily

Weekly

1

Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling

2

LinkedIn to shut down Israeli R&D operations and lay off nearly all employees

3

Corma raises $60 million Seed to build AI designed to fight AI-powered cyberattacks

4

Elbit’s $32 billion backlog is funding its next bet on warfare: airborne lasers

5

Talkspace co-founder Oren Frank dies at 60 after battle with cancer

Colossal Biosciences

1 stories about Colossal Biosciences

Sam Lamm holding Romulus, one of the cubs

"We took a 73,000-year-old fossil and created puppies from it. It's just magic"

02.06.25|Roni Dori

Biotech venture Colossal Biosciences stunned the world in April with the announcement that it had genetically engineered the dire wolf, a species that went extinct 12,500 years ago. But the excitement over the birth of three white puppies was quickly tempered by criticism: skeptics argued this was not a true species revival and warned that such investments could divert attention and resources from the urgent effort to protect existing wildlife. In an exclusive interview, founder Ben Lamm explains how the complex process was achieved, and why he believes it could ultimately benefit the planet.